Cite
HARVARD Citation
Bang, Y. et al. (n.d.). Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet oncology. 18 (12), pp. 1637-1651. [Online].